Laura M. Bogart

Dr. Laura M. Bogart

orcid

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 November 2020 in JAIDS Journal of Acquired Immune Deficiency Syndromes
Verified
Journal Article
Closed access
LBLaura M. Bogart
Laura M. Bogart
BOBisola O. Ojikutu
Bisola O. Ojikutu
KTKeshav Tyagi
Keshav Tyagi
DKDavid J. Klein
David J. Klein
MMMatt G. Mutchler
Matt G. Mutchler
SKSarah Kellman
Sarah Kellman
Background: Medical mistrust, a result of systemic racism, is prevalent among Black Americans and may play a role in COVID-19 inequities. In a convenience sample of HIV-positive Black Americans, we examined associations of COVID-19-related medical mistrust with COVID-19 vaccine and COVID-19 treatment hesitancy and negative impacts of COVID-19 on antiretroviral therapy (ART) adherence. Methods: Participants were 101 HIV-positive Black Americans (age: M = 50.3 years; SD = 11.5; 86% cisgender men; 77% sexual minority) enrolled in a randomized controlled trial of a community-based ART adherence intervention in Los Angeles County, CA. From May to July 2020, participants completed telephone interviews on negative COVID-19 impacts, general COVID-19 mistrust (eg, about the government withholding information), COVID-19 vaccine and treatment hesitancy, and trust in COVID-19 information sources. Adherence was monitored electronically with the Medication Event Monitoring System. Results: Nearly all participants (97%) endorsed at least one general COVID-19 mistrust belief, and more than half endorsed at least one COVID-19 vaccine or treatment hesitancy belief. Social service and health care providers were the most trusted sources. Greater COVID-19 mistrust was related to greater vaccine and treatment hesitancy [b (SE) = 0.85 (0.14), P < 0.0001 and b (SE) = 0.88 (0.14), P < 0.0001, respectively]. Participants experiencing more negative COVID-19 impacts showed lower ART adherence, assessed among a subset of 49 participants [b (SE) = −5.19 (2.08), P = 0.02]. Discussion: To prevent widening health inequities, health care providers should engage with communities to tailor strategies to overcome mistrust and deliver evidence-based information, to encourage COVID-19 vaccine and treatment uptake.

1 February 2005 in JAIDS Journal of Acquired Immune Deficiency Syndromes
Verified
Journal Article
Closed access
LBLaura M. Bogart
Laura M. Bogart
STSheryl Thorburn
Sheryl Thorburn
Objectives: This study examined endorsement of HIV/AIDS conspiracy beliefs and their relations to consistent condom use and condom attitudes among African Americans. Methods: We conducted a telephone survey with a random sample of 500 African Americans aged 15 to 44 years and living in the contiguous United States. Results: A significant proportion of respondents endorsed HIV/AIDS conspiracy beliefs. Among men, stronger conspiracy beliefs were significantly associated with more negative condom attitudes and inconsistent condom use independent of selected sociode-mographic characteristics, partner variables, sexually transmitted disease history, perceived risk, and psychosocial factors. In secondary follow-up analyses, men's attitudes about condom use partially mediated the effects of HIV/AIDS conspiracy beliefs on condom use behavior. Conclusions: HIV/AIDS conspiracy beliefs are a barrier to HIV prevention among African Americans and may represent a facet of negative attitudes about condoms among black men. To counter such beliefs, government and public health entities need to work toward obtaining the trust of black communities by addressing current discrimination within the health care system as well as by acknowledging the origin of conspiracy beliefs in the context of historical discrimination.

26 April 2007 in AIDS and Behavior
Verified
Journal Article
Closed access
PDF file
LBLaura M. Bogart
Laura M. Bogart
BCBurton O. Cowgill
Burton O. Cowgill
DKDavid Kennedy
David Kennedy
GRGery Ryan
Gery Ryan
DMDebra A. Murphy
Debra A. Murphy
MSMark A. Schuster
Mark A. Schuster

1 February 2007 in Journal of Urology
Verified
Journal Article
Closed access
LBLaura M. Bogart
Laura M. Bogart
SBSandra H. Berry
Sandra H. Berry
JCJ. Quentin Clemens
J. Quentin Clemens
In women symptoms of interstitial cystitis are difficult to distinguish from those of painful bladder syndrome and they appear to overlap with those of urinary tract infection, chronic urethral syndrome, overactive bladder, vulvodynia and endometriosis. This has led to difficulties in formulating a case definition for interstitial cystitis, and complications in the treatment and evaluation of its impact on the lives of women. We performed a systematic literature review to determine how best to distinguish interstitial cystitis from related conditions. We performed comprehensive literature searches using the terms diagnosis, and each of interstitial cystitis, painful bladder syndrome, urinary tract infection, overactive bladder, chronic urethral syndrome, vulvodynia and endometriosis. Of 2,680 screened titles 604 articles were read in full. The most commonly reported interstitial cystitis symptoms were bladder/pelvic pain, urgency, frequency and nocturia. Interstitial cystitis and painful bladder syndrome share the same cluster of symptoms. Chronic urethral syndrome is an outdated term. Self-reports regarding symptoms and effective antibiotic use can distinguish recurrent urinary tract infections from interstitial cystitis in some but not all women. Urine cultures may also be necessary. Pain distinguishes interstitial cystitis from overactive bladder and vulvar pain may distinguish vulvodynia from interstitial cystitis. Dysmenorrhea distinguishes endometriosis from interstitial cystitis, although many women have endometriosis plus interstitial cystitis. In terms of symptoms interstitial cystitis and painful bladder syndrome may be the same entity. Recurrent urinary tract infections may be distinguished from interstitial cystitis and painful bladder syndrome via a combination of self-report and urine culture information. Interstitial cystitis and painful bladder syndrome may be distinguished from overactive bladder, vulvodynia and endometriosis, although identifying interstitial cystitis and painful bladder syndrome in women with more than 1 of these diseases may be difficult.

1 January 2022 in Journal of the National Medical Association
Verified
Journal Article
Closed access
LBLaura M. Bogart
Laura M. Bogart
LDLu Dong
Lu Dong
PGPriya Gandhi
Priya Gandhi
DKDavid J. Klein
David J. Klein
TSTerry L. Smith
Terry L. Smith
BOBisola O. Ojikutu
Bisola O. Ojikutu

1 September 2016 in Social Science & Medicine
Verified
Journal Article
Closed access
LBLaura M. Bogart
Laura M. Bogart
GWGlenn J. Wagner
Glenn J. Wagner
HGHarold D. Green
Harold D. Green
MMMatt G. Mutchler
Matt G. Mutchler
DKDavid J. Klein
David J. Klein
CHCharles L. Hilliard
Charles L. Hilliard